Применение антикоагулянтов при остром коронарном синдроме

Clinical efficacy of unfractionated and low molecular heparins in acute coronary syndrome is discussed. New synthetic heparin derivative fondaparinux (Arixtra) is focused. Authors brief experience of fondaparinux clinical implementation is presented